Evidano home
Commentary on News

Qualitative Analysis of Hepatitis C Treatment Barriers

Evidano8 min read

Public health researchers need more than counts to explain why people diagnosed with Hepatitis C do not begin or complete treatment. The November 20, 2026 PLOS One study examined this problem in Los Angeles County by combining program data from 344 case-residents with interviews involving 10 participants. This article refracts the study through AI-enabled qualitative research, showing how thematic analysis can connect reported barriers, patient narratives, language needs, and treatment-access decisions. The discussion is research-focused and non-diagnostic: AI can accelerate synthesis, but public health teams must protect participant privacy, preserve context, and validate interpretations with trained researchers.

Key Takeaways

The PLOS One study, “Exploring barriers and facilitators to Hepatitis C virus treatment access in Los Angeles County: A mixed-methods study”, published on November 20, 2026, found that Hepatitis C treatment access was shaped by personal, provider-related, insurance, language, transportation, and healthcare-navigation barriers.

The study shows why qualitative analysis of hepatitis C treatment barriers matters: quantitative data identified how often barriers appeared, while interviews explained how those barriers affected treatment decisions and patient trust.

  • Between October 2024 and January 2025, the study examined de-identified program data from 344 Los Angeles County case-residents and conducted semi-structured interviews with 10 participants.
  • The study reported that 54% of case-residents experienced barriers; among the 91 people reporting specific barriers, personal barriers represented 43%, provider-related barriers 31%, insurance barriers 13%, and inadequate medical access 13%.
  • The qualitative sample included 7 untreated participants and 3 treated participants, with interviews conducted in English and Spanish.
  • Interview themes included homelessness, incarceration, drug addiction, language barriers, long provider wait times, cost, transportation, limited HCV information, family support, provider trust, and treatment motivation.
  • The authors recommended language support, patient navigation, care coordination, mobile clinics for people experiencing homelessness, continuity of care after incarceration, and fewer insurance restrictions.

What the Hepatitis C Treatment Access Study Measured

The November 20, 2026 PLOS One study used a convergent parallel mixed-methods design, analyzing quantitative program data and qualitative interviews separately before comparing their findings.

The quantitative component used descriptive frequencies and percentages from a linkage-to-cure program connected to the Los Angeles County Department of Public Health. The researchers did not conduct inferential statistical tests because most specific barrier categories contained fewer than 15 observations.

The qualitative component used inductive thematic analysis of verbatim interview transcripts. Research team members independently coded transcripts, met to compare codes, resolved discrepancies, and refined themes through repeated comparison across participant narratives.

The study was guided by the Health Belief Model and the Transtheoretical Model. The frameworks helped researchers distinguish individual beliefs and motivation from structural barriers involving providers, insurance, transportation, language, and healthcare access.

One untreated Spanish-speaking participant told the researchers, “Since I don’t speak 100% English... I didn’t understand very well what they were telling me.” The quotation illustrates why frequency counts alone cannot fully explain how language and communication affect treatment engagement.

The study authors reported several limitations, including the small qualitative sample, the uneven distribution between treated and untreated participants, and the inability to generalize the exploratory interview findings to all Los Angeles County residents.

Findings Snapshot for Public Health Researchers

Date or study periodMetricValueImplication for qualitative analysis
October 2024 to January 2025, according to the PLOS One studyCase-residents contacted344A mixed-methods workflow can connect program-scale patterns with a smaller set of detailed narratives.
October 2024 to January 2025, according to the PLOS One studyCase-residents already treated168, or 49%Treatment status provides a useful comparison segment for analyzing different care journeys.
October 2024 to January 2025, according to the PLOS One studyCase-residents who had not received treatment176Untreated participants can reveal barriers that are less visible in administrative records.
October 2024 to January 2025, according to the PLOS One studyCase-residents experiencing barriers54%Barrier prevalence can prioritize themes for deeper interview analysis.
October 2024 to January 2025, according to the PLOS One studyMost common reported barrier categoryPersonal barriers, 43% of the 91 people reporting specific barriersThematic analysis can unpack how housing, incarceration, addiction, knowledge, and motivation shape the category.
October 2024 to January 2025, according to the PLOS One studyInterview participants10 total, including 7 untreated and 3 treated participantsSmall samples can provide explanatory context, but findings require careful interpretation and should not be treated as population estimates.

Implications for AI-Enabled Public Health Research

AI-enabled qualitative research can help public health teams move from coded transcripts to structured comparisons without removing human responsibility for interpretation.

  • Segment by treatment status: The study compared treated and untreated experiences, so researchers can organize codes and excerpts by care stage before interpreting differences.
  • Analyze language and communication: Because the study included English and Spanish interviews, researchers can examine whether language, translation quality, and provider explanations recur across narratives.
  • Separate barrier levels: A useful code hierarchy can distinguish personal barriers, provider barriers, insurance barriers, and access barriers, then add subcodes such as cost, transportation, long waits, and limited information.
  • Link barriers to facilitators: The study identified motivation, family support, provider trust, insurance coverage, treatment knowledge, and stigma avoidance as facilitators that can be analyzed alongside obstacles.
  • Preserve quotes and context: AI-generated themes should remain connected to transcript excerpts, participant segments, and study limitations so researchers can audit how an interpretation was formed.

The November 20, 2026 study demonstrates that qualitative evidence adds explanatory depth to public health program data. AI can accelerate retrieval, coding support, comparison, and synthesis, but trained researchers should review sensitive interpretations involving stigma, substance use, homelessness, incarceration, language, and health access.

How Evidano Helps With Qualitative Analysis of Hepatitis C Treatment Barriers

Problem: Researchers need to synthesize interviews and program documents efficiently

Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents.

Researchers can upload transcripts, reports, and other documents to generate thematic, content, frequency, and cross-segment analyses. For a study like the Los Angeles County research, cross-segment analysis can help compare treated and untreated participants or English- and Spanish-language materials.

Researchers can review the resulting themes with supporting excerpts rather than relying on an unexplained summary. Learn more about Evidano’s qualitative research features.

Problem: Multilingual interviews can create transcription and translation bottlenecks

The PLOS One study conducted interviews in English and Spanish, making language handling an important part of the research workflow.

Evidano supports transcription with custom dictionaries and PII redaction, as well as translation with custom dictionaries. These capabilities can help teams standardize terminology while protecting identifying information during analysis.

Researchers should still verify translated excerpts and culturally sensitive interpretations with qualified bilingual reviewers.

Problem: Public health teams need an auditable path from themes to decisions

Evidano provides AI chat over uploaded documents and analyses, allowing researchers to ask focused questions about recurring barriers, segment differences, and evidence supporting a theme.

Visualizations such as word clouds, co-occurrence networks, and hierarchical codes-to-subcodes can help teams inspect relationships among concepts such as language, provider trust, transportation, cost, and treatment motivation.

Evidano encrypts data and states that customer data is never used to train third-party models. Teams should also follow their institutional review board, consent, retention, and data-governance requirements.

FAQ: Qualitative Analysis of Hepatitis C Treatment Barriers

What did the 2026 Los Angeles County study find about Hepatitis C treatment barriers?

The November 20, 2026 PLOS One study found that 54% of 344 case-residents experienced barriers to Hepatitis C treatment.

Among the 91 people reporting specific barriers, personal barriers accounted for 43%, provider-related barriers for 31%, insurance barriers for 13%, and inadequate medical access for 13%.

Why were qualitative interviews important in this Hepatitis C study?

Qualitative interviews explained why the barriers identified in program data affected treatment decisions and care experiences.

The 10 interviews added themes involving language, frustration navigating healthcare, long wait times, homelessness, incarceration, drug addiction, family support, and trust in providers.

How can AI support thematic analysis in public health research?

AI can support thematic analysis by helping researchers organize transcripts, identify recurring concepts, compare segments, retrieve supporting excerpts, and summarize coded evidence.

AI should support rather than replace researcher judgment, especially when the data involves stigma, vulnerable populations, language differences, or clinical access.

What sample size did the qualitative part of the study use?

The qualitative part of the study interviewed 10 participants, including 7 untreated participants and 3 treated participants, between October 2024 and January 2025.

The authors described the qualitative findings as exploratory and cautioned that the small, uneven sample limits generalizability.

What should researchers do before using AI on sensitive healthcare interviews?

Researchers should de-identify data, confirm consent and institutional approvals, apply appropriate access controls, and establish human review procedures before using AI for sensitive healthcare interviews.

The PLOS One study reported de-identifying interview data and receiving USC Institutional Review Board approval, identified as UP-24-00296.

Conclusion and Next Steps

The November 20, 2026 PLOS One study shows that Hepatitis C treatment access depends on both measurable barriers and lived experiences that require qualitative analysis to understand.

AI-enabled qualitative research can help public health teams compare treatment stages, analyze multilingual interviews, preserve supporting quotations, and connect patient narratives with program data.

Human researchers remain responsible for ethical data handling, contextual interpretation, validation, and decisions about policy or care interventions.

To analyze interviews, reports, and survey responses in one research workspace, try Evidano for free.

Topics

  • qualitative analysis of hepatitis C treatment barriers
  • AI qualitative research in public health
  • hepatitis C treatment access research
  • thematic analysis of healthcare interviews

Keep reading

Browse all articles